110 billion exosomes derived from chondrocyte cells—specialized cartilage cells known for their regenerative and anti-inflammatory properties. This targeted formulation is designed to support joint recovery after injury, tissue resilience, and musculoskeletal health.

For individuals suffering from joint pain and cartilage damage, exosome therapy offers a non surgical option to stimulate cartilage regeneration. This can possibly improve mobility and reduce pain for conditions like osteoarthritis and other degenerative joint diseases.